22nd Century Group Inc (NASDAQ:XXII)

0.2623
Delayed Data
As of Dec 01
 +0.0023 / +0.88%
Today’s Change
0.20
Today|||52-Week Range
18.98
-98.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$8.1M

Company Description

22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Contact Information

22nd Century Group, Inc.
500 Seneca Street
Buffalo New York 14204
P:(716) 270-1523
Investor Relations:

Employees

Shareholders

Other institutional4.88%
Mutual fund holders4.42%
Individual stakeholders--

Top Executives

Lawrence D. FirestoneChairman & Chief Executive Officer
Robert Hugh KinsmanChief Financial Officer
Juan Sanchez TamburrinoVice President-Research & Development
Calvin TreatChief Scientific Officer
John T. BrodfuehrerVice President-Strategy